大行評級|大華繼顯:上調京東目標價至220港元 強調對經營前景仍保持樂觀
大華繼顯發表研報指,京東2024年第四季盈利表現大幅超預期,以舊換新國家補貼政策推動收入強勁增長13%,較該行及市場預期高4%,Non-GAAP經營利潤及純利按年各增長34%。憧憬國補政策正面影響持續,該行將2025年首季及全年收入預測上調5%及4%,至按年增長10%及9%,將全年非通用會計準則淨利潤預測上調6%,至按年增長13%。
該行維持對京東“買入”評級,目標價從200港元上調至220港元,強調對經營前景仍保持樂觀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.